CRYPTOPHARMA PTY LTD
Cryptopharma Pty Ltd is a specialty pharmaceutical company directly involved in developing the next head lice treatment.
Similar Organizations
OnCusp Therapeutics
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
PhytoLab & Co.
PhytoLab is an independent, accredited and officially accredited testing laboratory for herbal medicines company in Vestenbergsgreuth.
Virtua Drug Ltd
Virtud Drug Ltd is an innovative bioinformatic company focusing on web development.
Current Employees Featured
Founder
More informations about "Cryptopharma Pty Ltd"
Cryptopharma Pty Ltd. - Drug pipelines, Patents, Clinical trials
Explore Cryptopharma Pty Ltd. with its drug pipeline, therapeutic area, technology platform, , Drug:CP-92.See details»
Cryptopharma Company Profile | Management and Employees List …
Cryptopharma is a Company focused on the discovery and development of novel anti-inflammatory therapeutics that address unmet needs in the treatment of pulmonary diseases . …See details»
Cryptopharma Pty Ltd - Crunchbase
Cryptopharma Pty Ltd is a specialty pharmaceutical company directly involved in developing the next head lice treatment. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Cryptopharma Pty Ltd - Contacts, Employees, Board Members
Cryptopharma Pty Ltd is a specialty pharmaceutical company directly involved in developing the next head lice treatment. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Cryptopharma - Overview, News & Competitors | ZoomInfo.com
View Cryptopharma (www.cryptopharma.com) location in Victoria, Australia , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
CP-92 - Drug Targets, Indications, Patents - Synapse - Patsnap
CP-92, Initially developed by Cryptopharma Pty Ltd., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Congenital Disorders,Digestive System …See details»
Cryptopharma - Products, Competitors, Financials, Employees ...
Cryptopharma raises $0.8m to progress cystic fibrosis drug Cryptopharma appoints David Crump as new CEO - GBS Venture Partners. Jun 27, 2013. Cryptopharma appoints David Crump as …See details»
Cryptopharma Pty. Ltd. - Company Profiles - BCIQ
For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, …See details»
Cryptopharma Pty Ltd | Qodeo
Cryptopharma Pty Ltd. Cryptopharma Pty Ltd Entrepreneur. Overview. About. Pitch. Financials. Investors. Overview; About. Pitch. Financials. Investors. Overview. Organization Details …See details»
John Nicholas Lambert - MarketScreener.com
May 3, 2011 John Nicholas Lambert is the founder of Cryptopharma Pty Ltd. founded in 2000. He worked as a Chief Executive Officer, Director & MD at Amplia Therapeutics Ltd. from 2020 …See details»
CRYPTOPHARMA PTY LTD, Patent Owner, PARKVILLE, AU
View CRYPTOPHARMA PTY LTD's, PARKVILLE, AU, patent portfolio profile on Patent Buddy. Patent Buddy is the world's most extensive database and networking website for patent …See details»
Cryptopharma CEO, Founder, Key Executive Team, Board of …
Explore {Cryptopharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Cryptopharma CEO, Founder, …See details»
Cryptopharma raises $0.8m to progress cystic fibrosis drug …
Melbourne-based pulmonary inflammation biotechnology company Cryptopharma Pty Ltd has appointed Dr David Crump as chief executive officer and completed an $800,000 capital …See details»
Cryptopharma Pty Ltd.:Acquisition,Acquisition Analysis & Reports ...
Discovery Company profile page for Cryptopharma Pty Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Cryptopharma nets $1.5m Start grant - labonline.com.au
University of Melbourne spin-off Cryptopharma has been awarded a AUD$1.5 million R&D Start grant to support its respiratory therapeutics program. CEO and co-founder Assoc Prof Alistair …See details»
John Lambert - Chief Executive Officer @ Amplia Therapeutics Ltd ...
John Lambert has 3 current jobs including Chief Executive Officer at Amplia Therapeutics Ltd., Vice President, Drug Development at Aviragen Therapeutics, and Founder at Cryptopharma …See details»
Cryptopharma's CP-92 selected as clinical lead
Apr 15, 2007 Cryptopharma's CP-92 selected as clinical lead 15 April 2007 Melbourne, Australia-based biotechnology firm Cryptopharma says that its inflammation drug candidate …See details»
The Development of New, Non-steroidal Anti-Asthma Drugs with …
The start-up biotech company Cryptopharma has recently identified a family of steroid derivatives that deliver, through a novel mode of action, significant anti-asthma activity in in-vivo models. …See details»
Crypto Pharma GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Crypto Pharma GmbH of Basel, BASEL-STADT. Get the latest business insights from Dun & Bradstreet.See details»
Lovisa Pty Ltd hiring Assistant Accountant - LinkedIn
Join to apply for the Assistant Accountant - Occupancy role at Lovisa Pty Ltd. First name. Last name. Email. Password (6+ characters) ... accuracy, consistency and organization • Excellent …See details»